+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Online Pharmacy Market in Europe- Industry Outlook and Forecast 2020-2025

  • PDF Icon

    Report

  • 184 Pages
  • April 2020
  • Region: Global
  • Arizton
  • ID: 5011314
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Get an in-depth analysis of COVID-19 impact on the online pharmacy market in Europe.

The online pharmacy market in Europe is expected to grow at a CAGR of over 14% during the period 2019–2025.

The growing internet penetration and the high prevalence of chronic diseases in developed countries have increased the popularity of online pharmacies in recent years. Online pharmacies are the most trending developments in several developing and developed countries in Europe. As the trend from offline to online is growing, there is major growth potential for healthcare companies to grow in southern European countries such as France, Germany, Italy, and Spain. Germany is the fastest-growing regional market due to the high-speed internet availability and increased awareness of online over-the-counter benefits. France and Italy are highly established markets that contribute to significant shares in the European market.

In several European countries, the expenditure on healthcare is increasing due to the allotment of high proportion of capital in the national financial budget. The actual factors contributing include the growth in chronic diseases and the increase in the aging population. To cope with such a scenario, an increasing proportion of GDP is spent on health in developing European countries. The UK is reforming the National Health Service, which was developed over sixty years ago to optimize healthcare while seeking high efficiency savings. A greater focus is on the prevention of diseases, public health, patient empowerment, and out-of-hospital care. Government initiatives toward healthcare are likely to boost online pharmacies as consumers will be inclined toward achieving better health, resulting in increased expenditure toward non-prescription medicines. Moreover, the growth of the online pharmacy market in Europe is heavily influenced by the growing internet penetration, implementation of e-prescriptions, improved virtual payment, and the aging population.

The following factors are likely to contribute to the growth of the online pharmacy market in Europe during the forecast period:
  • Growth in Internet Penetration
  • Increase in Economic Growth and Healthcare Expenditure
  • Rise in Self-medication
  • Availability of Large Product Offerings and Business Models

The study considers the present scenario of the online pharmacy market in Europe and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent companies operating in the market.

Online Pharmacy Market in Europe: Segmentation

This research report includes a detailed segmentation by platform, type, and geography. The over-the-counter (OTC) market is expected to grow at a CAGR of over 3% during the period 2019–2025. The segment is highly competitive and consists of several major players such as GlaxoSmithKline, PGT Healthcare, Sanofi, and Bayer. Online sales for OTC medicines have increased due to the relaxation of regulations in Europe. For example, Germany has been observing a steady growth after the introduction of NHS prescriptions, which is boosting the Europe online pharmacy market. In addition, the range of medicines covered under insurance schemes has also been reduced, thereby driving the virtual sales of OTC medicines.

The increasing proliferation of e-prescriptions is expected to drive the prescription medicine segment during the forecast period. The use of e-prescription is an important policy to improve healthcare in Europe. The policy aims to have a cross-border electronic healthcare system, which will enable citizens to obtain and use e-prescriptions anywhere in Europe. E-prescriptions are in demand due to the error-free prescription process and constant government efforts toward quality and affordable healthcare. The uneven proportion of patient-specialists further increases the need for accurate e-prescribing arrangements. Errors in prescription can occur due to a variety of reasons. Hence, e-prescriptions are expected to boost the online pharmacy industry as they will allow easy exchange and upload of prescriptions without having patients to scan the prescription to upload it. In 2018, approximately 1.5% of all prescription drugs in Germany were sold via online channels. The country is likely to introduce e-prescriptions in 2020, which is expected to open immense market opportunities for vendors.

In 2017, there were nearly 470 million unique mobile subscribers in Europe. In eastern and central Europe, the number is comparatively less than in Western Europe. In 2019, over 45% of residents in Western Europe used tablets, which are more than double of 21% user rate in Central and Eastern regions. The availability of high-speed broad internet and the increase in disposable incomes among Western Europe consumers are influencing the proliferation of mobile phones. The smartphone penetration in Western Europe is over 77%, followed by Eastern region with over 60%. In Western region, the share of mobile broadband subscriptions is high due to well-developed WCDMA networks and early LTE rollout. However, 4G is expected to reach its peak by 2023 as consumers are expected to upgrade to 5G services. In addition, there will be around 205 million 5G connections in Europe by 2025, which will be around 30% of total connections. Hence, the increasing penetration of mobile phones is expected to help the mobile segment to gain market shares during the forecast period.

Market Segmentation by Type
  • OTC
  • Prescription

Market Segmentation by Platform
  • Mobile
  • Desktop

Insights by Geography

The Europe online pharmacy market is concentrated in Germany, the UK, and France due to the presence of several vendors. While the growth of e-prescriptions and the tech-savvy population is growing across the region irrespective of demographic variabilities, the market is set to witness growth in the future. With the growing health awareness and increasing internet penetration, there is a high possibility of mobile and desktop owners opting for online medicine purchasing.
Germany is the largest online pharmacy market, with approximately 56% of the market shares in 2019. The UK and France are the second and third largest market, respectively and are likely to grow at the fastest rates due to growing mobile penetration, increasing the aging population, rising chronic diseases, growing strategic collaborations with health tech companies, and improving virtual payment modules.

Key Profiled Countries
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Poland
  • Sweden
  • Russia
  • Czech Republic

Insights by Vendors

The Europe online pharmacy market is growing, and it has achieved popularity and high penetration in the region, especially in the UK, Germany, the Netherlands, and Switzerland. However, there are no significant developments in countries such as Spain, Italy, Poland, and the Czech Republic, where there are immense opportunities for vendors to expand. The rapidly changing technological environment such as internet penetration and devices used to access the internet could be beneficial for vendors as these factors are leading to growth in online retail sales, thereby expecting to drive online pharmacy sales in the region. The present scenario is driving vendors to change and refine their unique value proposition to achieve a strong market presence. There is intense competition among vendors for the market share. Before online pharmacy, independent brick and mortar, as well as chain pharmacies, had a strong foothold in the market. The entry of major online pharmacies and will to expand in Europe and around the world had led them to acquire many renowned companies in the market.

Key Vendors
  • Zur Rose Group
  • SHOP APOTHEKE

Other Vendors
  • UK Meds
  • AMX Holdings
  • Parafarmacia-online
  • Newpharma
  • MonCoinSanté
  • MEDS
  • AZETA
  • Lloyds Pharmacy
  • Oxford Online Pharmacy
  • Chemist 4 U
  • Simple Online Pharmacy
  • myCARE
  • The Canadian Pharmacy
  • Juvalis
  • Apotea
  • Chemistdirect
  • Lékárna WPK
  • Pharmacy2U
  • Index Medical
  • inhousePharmacy
  • Prvalekarna
  • Cocooncente
  • DeOnlineDrogist
  • MedExpress
  • Farmacia Internacional
  • Lekarnar
  • BestPharmacy
  • Pharm24
  • Pharmacy4u
  • Vamida

Key Market Insights
The analysis of the online pharmacy market in Europe provides sizing and growth opportunities for the forecast period 2020–2025.
  • Provides comprehensive insights on the latest industry trends, forecast, and growth drivers in the market.
  • Includes a detailed analysis of growth drivers, challenges, and investment opportunities.
  • Delivers a complete overview of segments and the regional outlook of the market.
  • Offers an exhaustive summary of the vendor landscape, competitive analysis, and key strategies to gain competitive advantage.

Table of Contents

1 Research Methodology2 Research Objectives3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of The Study
4.3.1 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
8 Market Opportunities & Trends
8.1 Rise in Economic Growth, Per Capita Income, & Healthcare Spend Expenditure
8.2 Increase in Health Awareness & Demand for Self-Medication
8.3 Increased Collaboration Among Stakeholders
8.4 Large Product Offering, Competitive Price, Heavy Promotion, & Different Business Models
9 Market Growth Enablers
9.1 Growing Internet Penetration
9.2 Rising Implementation Of E-Prescriptions in Hospitals and Other Healthcare Services
9.3 Improving Online Payment
9.4 Increase in Chronic Diseases and Ageing Population
10 Market Restraints
10.1 Amazon Set to Enter Online Pharmacy Market
10.2 Strict Regulatory Frameworks to Curb Illegal Online Pharmacy Practices
10.3 Stiff Competition
10.4 Concentrated Market
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Market by Country
11.4 Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Medicine Type
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 OTC Medicines
12.3.1 Market Size & Forecast
12.3.2 Market Size & Forecast by Country
12.4 Prescription Medicines
12.4.1 Market Size & Forecast
12.4.2 Market Size & Forecast by Country
13 Platform Type
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Mobile
13.3.1 Market Size & Forecast
13.3.2 Market Size & Forecast by Country
13.4 Desktop
13.4.1 Market Size & Forecast
13.4.2 Market by Country
14 Country Segmentation
14.1 Market Snapshot & Growth Engine
14.2 Country Overview
15 Germany
15.1 Market Size & Forecast
15.2 Medicine Type
15.2.1 Market Size & Forecast
15.3 Platform Type
15.3.1 Market Size & Forecast
16 UK
16.1 Market Size & Forecast
16.2 Medicine Type
16.2.1 Market Size & Forecast
16.3 Platform Type
16.3.1 Market Size & Forecast
17 France
17.1 Market Size & Forecast
17.2 Medicine Type
17.2.1 Market Size & Forecast
17.3 Platform Type
17.3.1 Market Size & Forecast
18 Italy
18.1 Market Size & Forecast
18.2 Medicine Type
18.2.1 Market Size & Forecast
18.3 Platform Type
18.3.1 Market Size & Forecast
19 Spain
19.1 Market Size & Forecast
19.2 Medicine Type
19.2.1 Market Size & Forecast
19.3 Platform Type
19.3.1 Market Size & Forecast
20 Sweden
20.1 Market Size & Forecast
20.2 Medicine Type
20.2.1 Market Size & Forecast
20.3 Platform Type
20.3.1 Market Size & Forecast
21 The Netherlands
21.1 Market Size & Forecast
21.2 Medicine Type
21.2.1 Market Size & Forecast
21.3 Platform Type
21.3.1 Market Size & Forecast
22 Poland
22.1 Market Size & Forecast
22.2 Medicine Type
22.2.1 Market Size & Forecast
22.3 Platform Type
22.3.1 Market Size & Forecast
23 Switzerland
23.1 Market Size & Forecast
23.2 Medicine Type
23.2.1 Market Size & Forecast
23.3 Platform Type
23.3.1 Market Size & Forecast
24 Russia
24.1 Market Size & Forecast
24.2 Medicine Type
24.2.1 Market Size & Forecast
24.3 Platform Type
24.3.1 Market Size & Forecast
25 The Czech Republic
25.1 Market Size & Forecast
25.2 Medicine Type
25.2.1 Market Size & Forecast
25.3 Platform Type
25.3.1 Market Size & Forecast
26 Competitive Landscape
26.1 Competition Overview
27 Key Company Profiles
27.1 Zur Rose Group
27.1.1 Business Overview
27.1.2 Key Strategies
27.1.3 Key Strengths
27.1.4 Key Opportunities
27.2 Shop Apotheke
27.2.1 Business Overview
27.2.2 Key Strategies
27.2.3 Key Strengths
27.2.4 Key Opportunities
28 Other Prominent Vendors
28.1 UK MEDS
28.1.1 Business Overview
28.1.2 Key Strategies
28.1.3 Key Strengths
28.2 AMX HOLDINGS
28.2.1 Business Overview
28.2.2 Key Strategies
28.2.3 Key Strengths
28.3 PARAFARMACIA-ONLINE
28.3.1 Business Overview
28.3.2 Key Strategies
28.3.3 Key Strengths
28.4 NEWPHARMA
28.4.1 Business Overview
28.4.2 Key Strategies
28.4.3 Key Strengths
28.5 MONCOINSANTÉ
28.5.1 Business Overview
28.5.2 Key Strategies
28.5.3 Key Strengths
28.6 MEDS
28.6.1 Business Overview
28.6.2 Key Strategies
28.6.3 Key Strength
28.7 AZETA
28.7.1 Business Overview
28.7.2 Key Strategies
28.7.3 Key Strength
28.8 LLOYDS PHARMACY
28.8.1 Business Overview
28.8.2 Key Strategy
28.8.3 Key Strengths
28.9 OXFORD ONLINE PHARMACY
28.9.1 Business Overview
28.9.2 Key Strategy
28.9.3 Key Strengths
28.10 CHEMIST 4 U
28.10.1 Business Overview
28.10.2 Key Strategies
28.10.3 Key Strength
28.11 Simple Online Pharmacy
28.11.1 Business Overview
28.11.2 Key Strategy
28.11.3 Key Strength
28.12 Mycare
28.12.1 Business Overview
28.12.2 Key Strategy
28.12.3 Key Strengths
28.13 The Canadian Pharmacy
28.13.1 Business Overview
28.13.2 Key Strategy
28.13.3 Key Strength
28.14 Juvalis
28.14.1 Business Overview
28.14.2 Key Strengths
28.14.3 Key Strategies
28.15 APOTEA
28.15.1 Business Overview
28.15.2 Key Strategies
28.15.3 Key Strengths
28.16 CHEMISTDIRECT
28.16.1 Business Overview
28.16.2 Key Strategy
28.16.3 Key Strengths
28.17 Lékárna WPK
28.17.1 Key Strength
28.17.2 Key Strategy
28.18 PHARMACY2U
28.18.1 Business Overview
28.18.2 Key Strategies
28.18.3 Key Strengths
28.19 Index Medical
28.19.1 Business overview
28.19.2 Key Strategy
28.19.3 Key Strengths
28.20 INHOUSEPHARMACY
28.20.1 Business overview
28.20.2 Key Strategy
28.20.3 Key Strength
28.21 PRVALEKARNA
28.21.1 Business Overview
28.21.2 Key Strategy
28.21.3 Key Strength
28.22 COCOONCENTE
28.22.1 Business Overview
28.22.2 Key Strategies
28.22.3 Key Strength
28.23 DEONLINEDROGIST
28.23.1 Business Overview
28.23.2 Key Strategy
28.23.3 Key Strengths
28.24 MEDEXPRESS
28.24.1 Business Overview
28.24.2 Key Strategy
28.24.3 Key Strength
28.25 FARMACIA INTERNACIONAL
28.25.1 Business Overview
28.25.2 Key Strategies
28.25.3 Key Strength
28.26 LEKARNAR
28.26.1 Business Overview
28.26.2 Key Strategies
28.26.3 Key Strengths
28.27 BESTPHARMACY
28.27.1 Business Overview
28.27.2 Key Strategies
28.27.3 Key Strengths
28.28 PHARM24
28.28.1 Business Overview
28.28.2 Key Strategies
28.28.3 Key Strengths
28.29 PHARMACY4U
28.29.1 Business Overview
28.29.2 Key Strategy
28.29.3 Key Strength
28.30 VAMIDA
28.30.1 Business Overview
28.30.2 Key Strategies
28.30.3 Key Strengths
29 Report Summary
29.1 Key Takeaways
29.2 Strategic Recommendations
30 Quantitative Summary
30.1 Medicine Type
30.1.1 Europe: Market Size & Forecast
30.1.2 OTC Medicine: Market Size & Forecast
30.1.3 Prescription Medicine: Market Size & Forecast
30.2 Platform Type
30.2.1 Europe: Market Size & Forecast
30.2.2 Desktop: Market Size & Forecast
30.2.3 Mobile: Market Size & Forecast
30.3 Germany
30.3.1 Medicine Type
30.3.2 Platform Type
30.4 UK
30.4.1 Medicine Type
30.4.2 Platform Type
30.5 France
30.5.1 Medicine Type
30.5.2 Platform Type
30.6 Italy
30.6.1 Medicine Type
30.6.2 Platform Type
30.7 Spain
30.7.1 Medicine Type
30.7.2 Platform Type
30.8 SWEDEN
30.8.1 Medicine Type
30.8.2 Platform Type
30.9 Netherlands
30.9.1 Medicine Type
30.9.2 Platform Type
30.10 Poland
30.10.1 Medicine Type
30.10.2 Platform Type
30.11 Switzerland
30.11.1 Medicine Type
30.11.2 Platform Type
30.12 Russia
30.12.1 Medicine Type
30.12.2 Platform Type
30.13 The Czech Republic
30.13.1 Medicine Type
30.13.2 Platform Type
31 Appendix
31.1 Abbreviation

Companies mentioned

  • Zur Rose Group
  • SHOP APOTHEKE
  • UK Meds
  • AMX Holdings
  • Parafarmacia-online
  • Newpharma
  • MonCoinSanté
  • MEDS
  • AZETA
  • Lloyds Pharmacy
  • Oxford Online Pharmacy
  • Chemist 4 U
  • Simple Online Pharmacy
  • myCARE
  • The Canadian Pharmacy
  • Juvalis
  • Apotea
  • Chemistdirect
  • Lékárna WPK
  • Pharmacy2U
  • Index Medical
  • inhousePharmacy
  • Prvalekarna
  • Cocooncente
  • DeOnlineDrogist
  • MedExpress
  • Farmacia Internacional
  • Lekarnar
  • BestPharmacy
  • Pharm24
  • Pharmacy4u
  • Vamida

Methodology


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.



 

Loading
LOADING...